Back to search

University of South Florida

Overcoming Microenvironmentally Mediated Resistance in Targetable Non-Small Cell Lung Cancer

Abstract

dc:description

The introduction of targeted therapies has resulted in immense success in treating lung cancer patients, where many patients experience long-term remission. Yet, the tumors relapse into an advanced state of disease, and ultimately, treatment failure. This can be ascribed to incomplete eradication of tumor cells by targeted therapies, which enables the residual tumor cells to propagate resistant tumors and cause subsequent relapse in patients. Therapy sensitivity is influenced not only by cell-intrinsic mechanisms but also by inputs from the stromal microenvironment. Despite widespread recognition of the stromal microenvironment's role in modulating therapy sensitivity, its contribution to therapeutic responses in vivo remains insufficiently characterized. Here, we investigated the contribution of stroma-mediated resistance in xenograft models of ALK+ NSCLC against ALK-targeted therapies. We report that proximity to the stroma partially protects the tumor cells against ALK-targeted therapy. This protective effect is evident during both remission and relapse, indicating the importance of stroma-mediated resistance in both persistence of tumor cells and in therapeutic resistance. Our study reports that spatial aspects of stromal-mediated resistance effects, such as stromal abundance and dispersal, can influence the responses to the therapy. From a molecular mechanistic perspective, the protective effect of the stromal niche involves multiple mechanisms, including growth factors and extracellular matrix components, resulting in multifactorial effects that protect the tumor cells from therapy. Consequently, targeting individual resistance mechanisms can improve responses to targeted therapy but is insufficient to counteract the protective effects of stroma. Using both in vitro and in vivo validation experiments, we demonstrated that targeting shared collateral sensitivities of therapy-persister cells represents a more effective therapeutic approach. Together, our findings suggest that stroma-mediated resistance significantly contributes to both residual and progressive disease, underscoring limitations of strategies that target single resistance mechanisms. Our studies emphasize the need for a broader approach that considers the multifactorial nature of therapy resistance in overcoming therapy resistance.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Molecular Biosciences
Grantor
University of South Florida
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Desai, Bina
Contributors dc:contributor
  • Andriy Marusyk, Ph.D.
  • Eric Lau, Ph.D.
  • Karen Mann, Ph.D.
  • David Basanta, Ph.D.

Subjects

dc:subject × 6

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/11176

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Desai, Bina. Overcoming Microenvironmentally Mediated Resistance in Targetable Non-Small Cell Lung Cancer. Dissertation thesis, University of South Florida, 2024. https://digitalcommons.usf.edu/etd/11176